SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-24-022721
Filing Date
2024-03-15
Accepted
2024-03-14 18:41:57
Documents
21
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K ea0201816-10ka1_abvcbio.htm   iXBRL 10-K/A 110325
2 INSIDER TRADING POLICY ea020181601ex19-1_abvcbio.htm EX-19.1 54037
3 CERTIFICATION ea020181601ex31-1_abvcbio.htm EX-31.1 10593
4 CERTIFICATION ea020181601ex31-2_abvcbio.htm EX-31.2 10583
5 CERTIFICATION ea020181601ex32-1_abvcbio.htm EX-32.1 4380
6 CERTIFICATION ea020181601ex32-2_abvcbio.htm EX-32.2 4490
7 POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED INCENTIVE COMPENSATION ea020181601ex97_abvcbio.htm EX-97.1 20836
  Complete submission text file 0001213900-24-022721.txt   470477

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE abvc-20231231.xsd EX-101.SCH 3228
9 XBRL DEFINITION FILE abvc-20231231_def.xml EX-101.DEF 16959
10 XBRL LABEL FILE abvc-20231231_lab.xml EX-101.LAB 34962
11 XBRL PRESENTATION FILE abvc-20231231_pre.xml EX-101.PRE 18018
22 EXTRACTED XBRL INSTANCE DOCUMENT ea0201816-10ka1_abvcbio_htm.xml XML 6265
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40700 | Film No.: 24751778
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)